Passage Bio, Inc. Share Price
PASGPassage Bio, Inc. Stock Performance
Open $4.78 | Prev. Close $4.89 | Circuit Range N/A |
Day Range $4.75 - $4.78 | Year Range $3.33 - $19.81 | Volume 669 |
Average Traded $4.77 |
Passage Bio, Inc. Share Price Chart
About Passage Bio, Inc.
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Passage Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Jul-26 | $4.78 | $4.75 | -2.76% |
16-Jul-26 | $4.97 | $4.89 | -0.31% |
15-Jul-26 | $4.91 | $4.91 | +11.73% |
14-Jul-26 | $4.32 | $4.39 | +0.00% |
13-Jul-26 | $4.39 | $4.39 | -4.25% |
10-Jul-26 | $4.65 | $4.58 | -0.97% |
09-Jul-26 | $4.67 | $4.63 | -0.75% |
FAQs on Passage Bio, Inc. Share Price
Can I buy Passage Bio, Inc. shares in India?
What is the share price of Passage Bio, Inc.?
What is the 5 year returns of Passage Bio, Inc.?
What are the high & low stock price of Passage Bio, Inc. today?
What is the 52-week high and low of Passage Bio, Inc. stock?